European Union - English - EMA (European Medicines Agency)

glaxo group limited  - retigabine - epilepsy - antiepileptics, - trobalt is indicated as adjunctive treatment of drug-resistant partial-onset seizures with or without secondary generalisation in patients aged 18 years or older with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.

Egypt - English - EDA (Egyptian Drug Authority)

sanofi-synthelabo france - enteric coated tablet - 200 mg

Egypt - English - EDA (Egyptian Drug Authority)

sanofi-synthelabo france - syrup - 5.764 gm/100ml

Ireland - English - HPRA (Health Products Regulatory Authority)

chanelle medical unlimited company - nortriptyline hydrochloride - film-coated tablet - 10 milligram(s) - non-selective monoamine reuptake inhibitors; nortriptyline

Ireland - English - HPRA (Health Products Regulatory Authority)

chanelle medical unlimited company - nortriptyline hydrochloride - film-coated tablet - 25 milligram(s) - non-selective monoamine reuptake inhibitors; nortriptyline

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - celecoxib -

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - celecoxib, quantity: 200 mg - capsule, hard - excipient ingredients: carrageenan; titanium dioxide; sodium lauryl sulfate; gelatin; colloidal anhydrous silica; lactose monohydrate; magnesium stearate; iron oxide red; microcrystalline cellulose; iron oxide yellow; purified talc - for the symptomatic treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.,for the treatment of primary dysmenorrhoea in adults.,for the short-term treatment of acute pain in adults following surgery or musculoskeletal and/or soft tissue injury.

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - celecoxib, quantity: 100 mg - capsule, hard - excipient ingredients: microcrystalline cellulose; carrageenan; gelatin; magnesium stearate; sodium lauryl sulfate; lactose monohydrate; indigo carmine; titanium dioxide; purified talc; colloidal anhydrous silica - for the symptomatic treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.,for the treatment of primary dysmenorrhoea in adults.,for the short-term treatment of acute pain in adults following surgery or musculoskeletal and/or soft tissue injury.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - celecoxib -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - celecoxib, quantity: 200 mg - capsule, hard - excipient ingredients: carrageenan; titanium dioxide; sodium lauryl sulfate; gelatin; colloidal anhydrous silica; lactose monohydrate; magnesium stearate; iron oxide red; microcrystalline cellulose; iron oxide yellow; purified talc - for the symptomatic treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.,for the treatment of primary dysmenorrhoea in adults.,for the short-term treatment of acute pain in adults following surgery or musculoskeletal and/or soft tissue injury.